Clinical trial Recruiting at 1 site Observational Ages 18 and up

WB6Dim digital well-being: 3-day test-retest

Official title: Psychometric Validation of Test-Retest Reliability of the WB6Dim Digital Self-Assessment Tool for Well-Being Using a 3-Day Interval Protocol and Contamination Control

Run by Clover Link · NCT07433764 · Data updated 2026-11-12

This test checks whether the 28-item WB6Dim digital well-being questionnaire gives consistent results when French-speaking adults complete it twice, three days apart.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorClover Link
Industry-sponsored
Locations1 site (Bandol)
StatusRecruiting
StartedFebruary 19, 2026
Main results expectedFebruary 22, 2026
Study endsMay 9, 2026
Registry record updatedFebruary 25, 2026
Trial IDNCT07433764 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older who can read French, have internet access and an email address, and are willing to complete two short WB6Dim questionnaires three days apart are ideal candidates.

Probably not a fit

People who cannot read French, lack internet access, or who require a clinical diagnostic assessment rather than brief self-monitoring are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants complete the 28-item WB6Dim at baseline (T1) and again three days later (T2) to measure test-retest reliability across eight well-being dimensions. A contamination-control question at T2 identifies pairs with significant life events, and those pairs are excluded from the primary intraclass correlation (ICC) analyses. The study targets 220 usable pairs to produce 95% confidence intervals with a maximum width of .20 for ICC estimates, improving precision over prior work. An optional third assessment at nine weeks (T3) provides exploratory data on sensitivity to change after access to a well-being program but is not part of the primary design.

Why it matters

Potential benefit: If reliable, the WB6Dim could provide people and clinicians a quick, stable way to monitor multiple well-being dimensions digitally.

How similar studies have gone: A prior validation (N=295) showed strong internal consistency and convergent validity, and a 14-day test-retest (N=92) produced preliminary ICCs of .49 to .77, though the longer interval and limited pairs reduced confidence in those estimates.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years or older
* Able to read and understand French
* Access to an internet-connected device
* Willing to complete the WB6Dim questionnaire at T1 and T2
* Consent to anonymous data collection for research purposes

Exclusion Criteria:

* Under 18 years of age
* Unable to read or understand French

Where it's running

  • Clover Link
    Bandol, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.